Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: essential residues near the amino terminus - PubMed
Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: essential residues near the amino terminus
T J Hope et al. J Virol. 1990 Nov.
Abstract
The expression of certain mRNAs from human immunodeficiency virus type 1 (HIV-1) is controlled by the viral transactivator Rev, a nucleolar protein that binds a cis-acting element in these mRNAs. Rev is encoded by two viral exons that specify amino acids 1 to 26 and 27 to 116, respectively. Earlier studies have mapped essential regions of the protein that are encoded in the second exon. By further mutational analysis of Rev, we have now identified a novel locus encoded by the first exon that also is essential for transactivation in vivo. Defined by mutations at residues 14 to 20, this locus coincides with a cluster of positively charged and nonpolar amino acids that is conserved in Rev proteins of all known primate immunodeficiency viruses. Rev proteins that contained mutations at this site were defective in both nuclear localization and transactivation and did not function as trans-dominant inhibitors of wild-type Rev. Fusion of these mutants to a heterologous nuclear protein complemented the defect in localization but did not restore biological activity. Our findings suggest that this N-terminal locus may play a direct role in transactivation, perhaps contributing to essential protein-protein interactions or forming part of the RNA-binding domain of Rev.
Similar articles
-
Hope TJ, Huang XJ, McDonald D, Parslow TG. Hope TJ, et al. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7787-91. doi: 10.1073/pnas.87.19.7787. Proc Natl Acad Sci U S A. 1990. PMID: 2217212 Free PMC article.
-
Mutational definition of the human immunodeficiency virus type 1 Rev activation domain.
Malim MH, McCarn DF, Tiley LS, Cullen BR. Malim MH, et al. J Virol. 1991 Aug;65(8):4248-54. doi: 10.1128/JVI.65.8.4248-4254.1991. J Virol. 1991. PMID: 2072452 Free PMC article.
-
Böhnlein E, Berger J, Hauber J. Böhnlein E, et al. J Virol. 1991 Dec;65(12):7051-5. doi: 10.1128/JVI.65.12.7051-7055.1991. J Virol. 1991. PMID: 1942257 Free PMC article.
-
Bogerd HP, Huckaby GL, Ahmed YF, Hanly SM, Greene WC. Bogerd HP, et al. Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5704-8. doi: 10.1073/pnas.88.13.5704. Proc Natl Acad Sci U S A. 1991. PMID: 1905815 Free PMC article.
-
Pollard VW, Malim MH. Pollard VW, et al. Annu Rev Microbiol. 1998;52:491-532. doi: 10.1146/annurev.micro.52.1.491. Annu Rev Microbiol. 1998. PMID: 9891806 Review.
Cited by
-
Potent inhibition of HIV-1 replication by a Tat mutant.
Meredith LW, Sivakumaran H, Major L, Suhrbier A, Harrich D. Meredith LW, et al. PLoS One. 2009 Nov 10;4(11):e7769. doi: 10.1371/journal.pone.0007769. PLoS One. 2009. PMID: 19901984 Free PMC article.
-
Daugherty MD, D'Orso I, Frankel AD. Daugherty MD, et al. Mol Cell. 2008 Sep 26;31(6):824-34. doi: 10.1016/j.molcel.2008.07.016. Mol Cell. 2008. PMID: 18922466 Free PMC article.
-
LaBranche CC, Sauter MM, Haggarty BS, Vance PJ, Romano J, Hart TK, Bugelski PJ, Hoxie JA. LaBranche CC, et al. J Virol. 1994 Sep;68(9):5509-22. doi: 10.1128/JVI.68.9.5509-5522.1994. J Virol. 1994. PMID: 8057433 Free PMC article.
-
Polyvalent Rev decoys act as artificial Rev-responsive elements.
Symensma TL, Baskerville S, Yan A, Ellington AD. Symensma TL, et al. J Virol. 1999 May;73(5):4341-9. doi: 10.1128/JVI.73.5.4341-4349.1999. J Virol. 1999. PMID: 10196332 Free PMC article.
-
Cellular protein modulates effects of human immunodeficiency virus type 1 Rev.
Luo Y, Yu H, Peterlin BM. Luo Y, et al. J Virol. 1994 Jun;68(6):3850-6. doi: 10.1128/JVI.68.6.3850-3856.1994. J Virol. 1994. PMID: 8189522 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources